Sanofi SNY
NASDAQ SNY
$41.23 +0.49 (+1.20%)
At close: Sep 30, 2026 · 4:00 PM EDT

Sanofi (SNY) Non-Current Assets (2009 - 2026)

Updated

Sanofi (SNY) posted Non-Current Assets of $113.37 billion for the quarter ended Jun 30, 2026, up 13.9% from $99.55 billion a year earlier but down 1.0% from the prior quarter.

Analysis

Sanofi (SNY) Non-Current Assets (2009 - 2026) Analysis & Trends

As of Dec 31, 2025, Sanofi's Non-Current Assets came in at $108.3 billion, up 10.9% from the prior year.

  • Annual Non-Current Assets shows a five-year compound annual growth rate of 3.3% (years ended Dec 2020 to Dec 2025).
  • In prior years, Sanofi's Non-Current Assets was $97.64 billion in the year ended Dec 31, 2024 (-5.8%), $103.62 billion in the year ended Dec 31, 2023 (+6.2%), $97.61 billion in the year ended Dec 31, 2022 (-7.9%) and $106.02 billion in the year ended Dec 31, 2021 (+15.2%).
  • Quarterly Non-Current Assets has run from a low of $92.43 billion in the quarter ended Mar 31, 2025 to a high of $114.57 billion in the quarter ended Mar 31, 2026 over five years.
  • On a year-over-year basis, Non-Current Assets has increased in each of the last three quarters, with growth averaging 8.0% over the last five quarters.
  • The strongest year-over-year quarter for Non-Current Assets in the past five years was the quarter ended Mar 31, 2026, with growth of 23.9%; the weakest was the quarter ended Dec 31, 2022, with a decline of 7.8%.
  • According to Business Quant data, Non-Current Assets for the three prior quarters was $114.57 billion (quarter ended Mar 31, 2026), $111.58 billion (quarter ended Dec 31, 2025) and $111.94 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 141.29 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 101.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 87.87 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 35.42 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 14.88 Bn
10 Sanofi 50.28 Bn 17.06 Bn 10.79 Bn 113.37 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 113.37 Bn
Mar 31, 2026 114.57 Bn
Dec 31, 2025 111.58 Bn
Sep 30, 2025 111.94 Bn
Jun 30, 2025 99.55 Bn
Mar 31, 2025 92.43 Bn
Dec 31, 2024 96.40 Bn
Jun 30, 2024 107.34 Bn
Dec 31, 2023 103.07 Bn
Jun 30, 2023 103.57 Bn
Dec 31, 2022 94.49 Bn
Jun 30, 2022 99.43 Bn
Dec 31, 2021 102.49 Bn
Jun 30, 2021 99.62 Bn
Dec 31, 2020 96.13 Bn
Jun 30, 2020 89.15 Bn
Dec 31, 2019 667.01 Mn
Jun 30, 2019 95.69 Bn
Dec 31, 2018 99.03 Bn
Jun 30, 2018 104.20 Bn
API Access

Sanofi Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=SNY&period=max&api_key=YOUR_API_KEY